Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Eye and Vision (London, England)
|
November 10, 2018
Microvascular blood flow velocities measured with a retinal function imager: inter-eye correlations in healthy controls and an exploration in multiple sclerosis
Liang Wang, Ohemaa Kwakyi, James Nguyen, et al.
Multiple Sclerosis and Related Disorders
|
May 31, 2016
Characterizing retinal structure injury in African-Americans with multiple sclerosis
Navid Seraji-Bozorgzad, Sheridan Reed, Fen Bao, et al.
Plos One
|
January 23, 2016
Correlating Function and Imaging Measures of the Medial Longitudinal Fasciculus
Ken Sakaie, Masaya Takahashi, Gina Remington, et al.
Neurology
|
January 23, 2015
Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis
Jiwon Oh, Elias S Sotirchos, Shiv Saidha, et al.
Current Eye Research
|
December 15, 2017
Analysis of Agreement of Retinal-Layer Thickness Measures Derived from the Segmentation of Horizontal and Vertical Spectralis OCT Macular Scans
Natalia Gonzalez Caldito, Bhavna Antony, Yufan He, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 15, 2015
Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response
Nicholas A Hubbard, Monroe Turner, Joanna L Hutchison, et al.
Ophthalmology
|
February 28, 2012
Ganglion cell loss in relation to visual disability in multiple sclerosis
Scott D Walter, Hiroshi Ishikawa, Kristin M Galetta, et al.
JAMA Neurology
|
March 27, 2013
Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis
Benjamin M Greenberg, Laura Balcer, Peter A Calabresi, et al.
Clinical Therapeutics
|
June 11, 2004
A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of Avonex in patients with multiple sclerosis
J Theodore Phillips, George Rice, Elliot Frohman, et al.
Plos Pathogens
|
November 13, 2012
Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy
Molly R Perkins, Caroline Ryschkewitsch, Julia C Liebner, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Eye and Vision (London, England)
|
November 10, 2018
Microvascular blood flow velocities measured with a retinal function imager: inter-eye correlations in healthy controls and an exploration in multiple sclerosis
Liang Wang, Ohemaa Kwakyi, James Nguyen, et al.
Multiple Sclerosis and Related Disorders
|
May 31, 2016
Characterizing retinal structure injury in African-Americans with multiple sclerosis
Navid Seraji-Bozorgzad, Sheridan Reed, Fen Bao, et al.
Plos One
|
January 23, 2016
Correlating Function and Imaging Measures of the Medial Longitudinal Fasciculus
Ken Sakaie, Masaya Takahashi, Gina Remington, et al.
Neurology
|
January 23, 2015
Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis
Jiwon Oh, Elias S Sotirchos, Shiv Saidha, et al.
Current Eye Research
|
December 15, 2017
Analysis of Agreement of Retinal-Layer Thickness Measures Derived from the Segmentation of Horizontal and Vertical Spectralis OCT Macular Scans
Natalia Gonzalez Caldito, Bhavna Antony, Yufan He, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 15, 2015
Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response
Nicholas A Hubbard, Monroe Turner, Joanna L Hutchison, et al.
Ophthalmology
|
February 28, 2012
Ganglion cell loss in relation to visual disability in multiple sclerosis
Scott D Walter, Hiroshi Ishikawa, Kristin M Galetta, et al.
JAMA Neurology
|
March 27, 2013
Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis
Benjamin M Greenberg, Laura Balcer, Peter A Calabresi, et al.
Clinical Therapeutics
|
June 11, 2004
A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of Avonex in patients with multiple sclerosis
J Theodore Phillips, George Rice, Elliot Frohman, et al.
Plos Pathogens
|
November 13, 2012
Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy
Molly R Perkins, Caroline Ryschkewitsch, Julia C Liebner, et al.
Page
of 5